Fig. 3
The chromatogram of: (—) the blank and (—) synthetic pharmaceutical formulation containing TAM (1.0 µg mL−1) and TTD (10.0 µg mL−1) using 280 nm and 350 nm as excitation and emission wavelengths, respectively.
Fig. 3 | Scientific Reports
The chromatogram of: (—) the blank and (—) synthetic pharmaceutical formulation containing TAM (1.0 µg mL−1) and TTD (10.0 µg mL−1) using 280 nm and 350 nm as excitation and emission wavelengths, respectively.
